AccessibilityHelpAbout Us
Cooper Companies logo

Cooper Companies(NASDAQ) COO

Market Cap$10.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1983)+706%
5 Year-50%
1 Year-19%
1 Month-24%
Premium Feature
Moneyball Superscore
65/100
$55.38
-1.24%
-0.70Today
After hours$55.39+$0.01 (+0.03%)
Cooper Companies last closing stock price
MetricPriceDate
Last closeUSD 55.382026-09-24
Cooper Companies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.98%USD 53.782026-09-17
1 month-24.18%USD 73.042026-08-25
3 month-22.02%USD 71.022026-06-26
Year to date-32.43%USD 81.962025-12-31
1 year-18.98%USD 68.352025-09-24
3 year-33.15%USD 82.842023-09-25
5 year-49.57%USD 109.812021-09-24
Since inception+706.43%USD 6.871983-05-10

Cooper Companies Financials at a Glance

Market Cap

$10.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$4.24B

Net Income (TTM)

$570.30M

EPS (TTM)

$2.93

P/E Ratio

18.90

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$55.38

Volume

6,253,522.838

Open

$56.06

Previous Close

$55.38

Daily Range

$54.85 - $56.64

52-Week Range

$51.01 - $89.83

Estimated Earnings Date

Dec 3, 2026

COO News

healthcare--doctor-with-tablet-in-hospital--neutral

Why is CooperCompanies Stock Down 15% Today?

Johnny RiceSep 10, 2026
Person undergoing an eye exam

Why Cooper Companies Stock Sank by 13% Today

Eric VolkmanAug 28, 2025
Foolcom-Featured.png

Cooper Companies Posts 15% EPS Gain

Motley Fool Markets TeamAug 27, 2025
Person undergoing an eye exam

Why Cooper Companies Stock Triumphed on Thursday

Eric VolkmanAug 29, 2024
Friends riding a roller coaster

Tired of the Tesla Roller Coaster? Try These Safer Stocks Instead

Scott LevineSep 12, 2020
GettyImages-1126314258

3 Recession-Resistant Stocks to Buy Right Now

Lee SamahaApr 12, 2020
Longview3

Cooper Companies Inc Stock Is Sinking On Disappointing Fourth-Quarter Results

George Budwell, PhDDec 4, 2015
cooper1

5 Reasons to Buy This Health Care Stock -- and Why to Avoid It

Lee SamahaOct 2, 2013
Page 1

COO: Motley Fool Moneyball Superscore

65

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cooper Companies

The Cooper Companies, Inc. helps people see with contact lenses. It also provides medical tools for women’s health needs. These products support patients and doctors across the world.

Vision and Family Health Care

  • CooperVision: Contact lenses for nearsightedness, astigmatism, and presbyopia; generated $2,135.6 million in net sales during the nine months ended July 31, 2026.
  • Office and Surgical: Medical devices for procedures performed by obstetricians and gynecologists; generated $624.6 million in net sales during the same period.
  • Fertility Services: Products and genetic testing that support the in vitro fertilization process; generated $411.6 million in net sales during the same period.
  • Specialty Lenses: Orthokeratology and scleral lenses for myopia management and specialized vision care.

Strategic Steps Forward

  • Approved an increase of $1.0 billion to the share repurchase program in September 2026.
  • Secured approvals for the MiSight 1 day lens in China and Japan following regulatory reviews.
  • Completed a group restructuring in November 2020 to establish headquarters in the United Kingdom.
  • Entered into a $2.3 billion revolving credit agreement in May 2024 to manage outstanding debt.

Global Scale and Innovation

The company maintains a global reach with sales teams in the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. It focuses on single-use silicone hydrogel technology to meet shifting consumer demand in the contact lens market.

Measuring Financial Progress

  • CooperVision net sales were $2,135.6 million for the nine months ended July 31, 2026, up 5% year over year.
  • Consolidated operating income was $403.8 million for the nine months ended July 31, 2026, down 26% year over year.
  • Recognized a discrete income tax benefit of $307.2 million in the three months ended July 31, 2026.
  • CooperSurgical reported a $157.1 million operating loss for the nine months ended July 31, 2026, due to litigation costs.

Bottom Line

Cooper has transformed into a diversified medical device manufacturer with strong positions in vision and women's health. Its focus on specialized medical consumables provides a foundation for global operations.

AI Generated • Sep 10, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

15,000

CEO

Albert George White, III, MBA

Website

www.coopercos.com

Headquarters

San Ramon, CA 94583, US

COO Financials

Key Financial Metrics (TTM)

Gross Margin

63.64%

Operating Margin

12.85%

Net Income Margin

13.46%

Return on Equity

6.88%

Return on Capital

6.20%

Return on Assets

4.50%

Earnings Yield

5.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

190.16M

Volume

6.25M

Avg. Volume

2.97M

Financials (TTM)

Gross Profit

$2.70B

Operating Income

$544.60M

EBITDA

$910.20M

Operating Cash Flow

$1.03B

Capital Expenditure

-$355.30M

Free Cash Flow

$678.00M

Cash & ST Invst.

$154.70M

Total Debt

$2.54B

Cooper Companies Performance Analysis

Cooper Companies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-10-31USD 3,308,400,00013.2%
20232023-10-31USD 3,593,200,0008.6%
20242024-10-31USD 3,895,400,0008.4%
20252025-10-31USD 4,092,400,0005.1%
Cooper Companies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-10-310.5%
Q12026-01-31-3.9%
Q22026-04-305.6%
Q32026-07-31-1.4%
Cooper Companies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-10-31USD 1.94-86.9%
20232023-10-31USD 1.48-23.9%
20242024-10-31USD 1.9632.5%
20252025-10-31USD 1.87-4.2%
Cooper Companies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-10-31-12.2%
Q12026-01-3153.5%
Q22026-04-30-160.6%
Q32026-07-31660.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$1.07B

+0.6%

Gross Profit

$664.90M

-3.9%

Gross Margin

62.36%

N/A

Market Cap

$10.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$702.05K

N/A

Employees

15,000

N/A

Net Income

$432.80M

+340.3%

EBITDA

$317.00M

+16.2%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$154.70M

+23.9%

Total Debt

$2.54B

+2.7%

Accounts Receivable

$788.90M

-0.4%

Inventory

$911.50M

+3.5%

Long Term Debt

$1.92B

-21.2%

Short Term Debt

$628.10M

+1214.0%

Return on Assets

4.50%

N/A

Return on Invested Capital

5.04%

N/A

Free Cash Flow

$273.00M

+66.0%

Operating Cash Flow

$341.70M

+30.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UHSUniversal Health Services, Inc.
$176.99-2.43%
SNNSmith & Nephew plc
$26.68-0.52%
FMSFresenius Medical Care AG & Co. KGaA
$22.35-0.27%
SMMTSummit Therapeutics Inc.
$16.38-0.43%

Trending Stocks

Symbol / CompanyPricePrice Chg
GLNDGreenland Energy
$5.35+83.85%
INTCIntel
$127.39+3.91%
ONDSOndas
$7.60+2.70%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$33.63-0.09%

Questions About COO

What is the current price of Cooper Companies?

Cooper Companies is trading at $55.38 per share.

What is the 52-week range for Cooper Companies?

Over the past 52 weeks, Cooper Companies has traded between $51.01 and $89.83.

How much debt does Cooper Companies have?

As of the most recent reporting period, Cooper Companies reported total debt of $2.54B.

How much cash does Cooper Companies have on hand?

Cooper Companies reported $154.90M in cash and cash equivalents in its most recent financial results.

What is Cooper Companies’s dividend yield?

Cooper Companies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services